CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 130 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $372,750 | +36.2% | 25,000 | 0.0% | 0.01% | +37.5% |
Q2 2023 | $273,750 | +25.6% | 25,000 | 0.0% | 0.01% | +14.3% |
Q1 2023 | $218,000 | +39.1% | 25,000 | 0.0% | 0.01% | +40.0% |
Q4 2022 | $156,750 | +78.1% | 25,000 | 0.0% | 0.01% | +25.0% |
Q3 2022 | $88,000 | +18.9% | 25,000 | 0.0% | 0.00% | +33.3% |
Q2 2022 | $74,000 | -5.1% | 25,000 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $78,000 | -8.2% | 25,000 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $85,000 | -53.6% | 25,000 | -50.0% | 0.00% | -66.7% |
Q3 2021 | $183,000 | +64.9% | 50,000 | +100.0% | 0.01% | +50.0% |
Q2 2021 | $111,000 | -2.6% | 25,000 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $114,000 | -20.8% | 25,000 | 0.0% | 0.01% | -33.3% |
Q4 2020 | $144,000 | +61.8% | 25,000 | 0.0% | 0.01% | +50.0% |
Q3 2020 | $89,000 | +2.3% | 25,000 | 0.0% | 0.01% | -14.3% |
Q2 2020 | $87,000 | +135.1% | 25,000 | 0.0% | 0.01% | +75.0% |
Q1 2020 | $37,000 | -24.5% | 25,000 | 0.0% | 0.00% | +33.3% |
Q4 2019 | $49,000 | – | 25,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 1,641,804 | $7,454,000 | 6.54% |
COMMODORE CAPITAL LP | 2,983,513 | $13,545,000 | 5.40% |
Foresite Capital Management IV, LLC | 1,787,094 | $8,113,000 | 0.97% |
Avoro Capital Advisors LLC | 10,300,000 | $46,762,000 | 0.81% |
Boxer Capital, LLC | 4,000,000 | $18,160,000 | 0.62% |
Sio Capital Management, LLC | 562,339 | $2,553,000 | 0.52% |
ACUTA CAPITAL PARTNERS, LLC | 315,341 | $1,432,000 | 0.52% |
CM Management, LLC | 150,000 | $681,000 | 0.51% |
APIS CAPITAL ADVISORS, LLC | 120,000 | $545,000 | 0.50% |
Versant Venture Management, LLC | 543,753 | $2,469,000 | 0.48% |